Results 161 to 170 of about 91,203 (305)
Why are we still missing the pain? Rethinking diabetic neuropathy in primary care - lessons from the REGENERAR study. [PDF]
Future Sci OAAlcántara Montero A.
europepmc +1 more source
Novel approaches for drug development against chronic primary pain: A systematic review
British Journal of Pharmacology, EarlyView.Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
Role of astrocytes in diabetic neuropathy: Review of their involvement in disease mechanisms. [PDF]
World J DiabetesHaris K, Long I.
europepmc +1 more source
Combination therapy in treatment of peripheral diabetic neuropathy with severe pain in an adolescent patient [PDF]
, 2009 Can Eyigör +3 more
openalex +1 more source
British Journal of Pharmacology, EarlyView.Abstract Chronic pain, marked by nociceptive sensitization and maladaptive neuroplasticity, affects 30% of the global population with escalating socioeconomic burdens. Epidemiological data show a 2‐3‐fold increase in neuropsychiatric co‐morbidities among individuals with chronic pain, where epigenetic dysregulation serves as a key mechanism linking ...
Kai Zhang +18 more
wiley +1 more source
Identification of novel therapeutic targets for diabetic neuropathy through integrated proteomics and transcriptomics approaches. [PDF]
World J DiabetesDing XF, Dang X, Lin S.
europepmc +1 more source
Infective endocarditis after multiple rat bites in a patient with diabetic neuropathy: If not Streptobacillus moniliformis, what else should be suspected? [PDF]
, 2015 Wanis Ibrahim +2 more
openalex +1 more source